Brian Godman

19.3k total citations
526 papers, 10.3k citations indexed

About

Brian Godman is a scholar working on Economics and Econometrics, Applied Microbiology and Biotechnology and General Health Professions. According to data from OpenAlex, Brian Godman has authored 526 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Economics and Econometrics, 164 papers in Applied Microbiology and Biotechnology and 94 papers in General Health Professions. Recurrent topics in Brian Godman's work include Antibiotic Use and Resistance (164 papers), Pharmaceutical Economics and Policy (149 papers) and Health Systems, Economic Evaluations, Quality of Life (141 papers). Brian Godman is often cited by papers focused on Antibiotic Use and Resistance (164 papers), Pharmaceutical Economics and Policy (149 papers) and Health Systems, Economic Evaluations, Quality of Life (141 papers). Brian Godman collaborates with scholars based in United Kingdom, South Africa and Sweden. Brian Godman's co-authors include Johanna C. Meyer, Björn Wettermark, Amanj Kurdi, Marion Bennie, Lars L. Gustafsson, Mohamed Azmi Hassali, Alan Haycox, Stephen Campbell, Zikria Saleem and Augusto Afonso Guerra and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Brian Godman

505 papers receiving 10.0k citations

Peers

Countries citing papers authored by Brian Godman

Since Specialization

Citations

This map shows the geographic impact of Brian Godman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Godman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Godman more than expected).

Fields of papers citing papers by Brian Godman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Godman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Godman. The network helps show where Brian Godman may publish in the future.

Co-authorship network of co-authors of Brian Godman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Godman. A scholar is included among the top collaborators of Brian Godman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Godman. Brian Godman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors and outcomes of patients with COVID-19 admitted to intensive care units in Pakistan and the development of nosocomial fungal infections: Findings and implications 2024 ·IJID Regions ·Zia Ul Mustafa, (unknown), (unknown), Muhammad Salman, (unknown), Tauqeer Hussain Mallhi, Yusra Habib Khan, Steward Mudenda, Johanna C. Meyer, Brian Godman, R.A. Seaton	1
2	Users’ Perceptions of Access to and Quality of Unified Health System Services in Brazil: A Cross-Sectional Study and Implications to Healthcare Management Challenges 2024 ·International Journal of Environmental Research and Public Health ·(unknown), Edna Afonso Reis, Brian Godman, Stephen Campbell, Johanna C. Meyer, (unknown), Isabella Piassi Dias Godói	2
3	Culture-Independent Quantitative PCR Detected Mobilized Colistin Resistance Genes (mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5) in Chicken Gut Contents in Bangladesh 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Md Nahidul Islam, Shamsun Nahar, Brian Godman, Salequl Islam	2
4	Resistance and Co-Resistance of Metallo-Beta-Lactamase Genes in Diarrheal and Urinary-Tract Pathogens in Bangladesh 2024 ·Microorganisms ·(unknown), Md Nahidul Islam, (unknown), (unknown), (unknown), (unknown), Shamsun Nahar, Brian Godman, Salequl Islam	3
5	Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications 2023 ·Revista da Sociedade Brasileira de Medicina Tropical ·Zia Ul Mustafa, (unknown), (unknown), Muhammad Salman, (unknown), Yusra Habib Khan, Tauqeer Hussain Mallhi, Brian Godman	3
6	Knowledge and Perceptions of Final-Year Nursing Students Regarding Antimicrobials, Antimicrobial Resistance, and Antimicrobial Stewardship in South Africa: Findings and Implications to Reduce Resistance 2023 ·Antibiotics ·(unknown), (unknown), Johanna C. Meyer, Brian Godman, (unknown)	4
7	Antimicrobial Dispensing Practices during COVID-19 and the Implications for Pakistan 2023 ·Antibiotics ·(unknown), Maria Elena Sana, (unknown), Zia Ul Mustafa, Muhammad Salman, Yusra Habib Khan, Tauqeer Hussain Mallhi, (unknown), Johanna C. Meyer, Brian Godman	10
8	COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients: A Cross-Sectional Study and the Implications for Pakistan and Beyond 2023 ·Vaccines ·(unknown), (unknown), (unknown), Muhammad Salman, Mohamed A. Baraka, Zia Ul Mustafa, Yusra Habib Khan, Tauqeer Hussain Mallhi, Syed Shahzad Hasan, Johanna C. Meyer, Brian Godman	5
9	COVID-19 Vaccine Acceptance and Hesitancy among Healthcare Workers in Lusaka, Zambia; Findings and Implications for the Future 2023 ·Vaccines ·Steward Mudenda, Victor Daka, Scott Kaba Matafwali, (unknown), Billy Chabalenge, Moses Mukosha, Joseph Fadare, Ruth Lindizyani Mfune, Bwalya A. Witika, (unknown), Webrod Mufwambi, Brian Godman, Johanna C. Meyer, (unknown)	12
10	Antibiotic Susceptibility Surveillance in the Punjab Province of Pakistan: Findings and Implications 2023 ·Medicina ·Zikria Saleem, Abdul Haseeb, Safa S. Almarzoky Abuhussain, Catrin E. Moore, (unknown), Muhammad Usman Qamar, (unknown), Giuseppe Pichierri, (unknown), (unknown), Amna Saeed, Afreenish Amir, Furqan Khurshid Hashmi, Johanna C. Meyer, Israel Abebrese Sefah, (unknown), (unknown), Brian Godman	17
11	Knowledge, attitude, and practices toward infection prevention and control among undergraduate pharmacy students in Zambia: findings and implications 2023 ·SHILAP Revista de lepidopterología ·Steward Mudenda, (unknown), Billy Chabalenge, Maisa Kasanga, Scott Kaba Matafwali, Victor Daka, Kaunda Yamba, (unknown), Webrod Mufwambi, (unknown), Brian Godman	6
12	Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications 2022 ·Antibiotics ·Zikria Saleem, Abdul Haseeb, Brian Godman, (unknown), (unknown), (unknown), Faiz Ullah Khan, Zia Ul Mustafa, (unknown), Muhammad Junaid Farrukh, (unknown), (unknown), Amer Hayat Khan, Hamid Saeed, (unknown), Mohamed Raafat, (unknown), Muhammad Shahid Iqbal	19
13	Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa 2021 ·Hospital Practice ·(unknown), (unknown), Johanna C. Meyer, Brian Godman, Amanj Kurdi, Marilyn Lennon, Marion Bennie, Natalie Schellack	13
14	Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications 2020 ·Expert Review of Clinical Pharmacology ·Jaykaran Charan, Rimple Jeet Kaur, Pankaj Bhardwaj, Mainul Haque, Praveen Sharma, Sanjeev Misra, Brian Godman	53
15	Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study 2020 ·Current Medical Research and Opinion ·Francisco de Assis Acúrcio, Augusto Afonso Guerra, (unknown), (unknown), Brian Godman, Marion Bennie, Hacene Nedjar, Elham Rahme	12
16	A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications 2019 ·Hospital Practice ·Zikria Saleem, Mohamed Azmi Hassali, Furqan Khurshid Hashmi, Brian Godman, (unknown)	8
17	Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis 2019 ·PLoS ONE ·Lívia Lovato Pires de Lemos, Mírian Carvalho de Souza, (unknown), (unknown), Brian Godman, Stéphane Verguet, Augusto Afonso Guerra, Mariângela Leal Cherchiglia	40
18	Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications 2014 ·BMC Medicine ·Brian Godman, Max Petzold, Kathleen Bennett, Marion Bennie, Anna Bucsics, Alexander Finlayson, Andrew Martin, (unknown), Jutta Piessnegger, Emanuel Raschi, Steven Simoens, Corinne Zara, Corrado Barbui	28
19	Initiatives to improve prescribing efficiency in China and their influence : cardio-cerebral vascular medicines as a case history to provide future direction 2014 ·Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) ·Brian Godman, (unknown), (unknown), Mengying Feng, Alexander Finlayson, Stephen Campbell	1
20	PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) 2013 ·Pharmacoepidemiology and Drug Safety ·(unknown), Ian Bates, (unknown), (unknown), (unknown), Brian Godman, Andrew Martin, (unknown), (unknown), K. Vanaja, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact